UBS Group’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $588K | Sell |
|
|||||
|
2025
Q1 | $671K | Buy |
|
|||||
|
2024
Q4 | $330K | Sell |
|
|||||
|
2024
Q3 | $648K | Buy |
|
|||||
|
2024
Q2 | $172K | Sell |
|
|||||
|
2024
Q1 | $348K | Sell |
|
|||||
|
2023
Q4 | $350K | Buy |
|
|||||
|
2023
Q3 | $127K | Sell |
|
|||||
|
2023
Q2 | $157K | Buy |
|
|||||
|
2023
Q1 | $111K | Buy |
|
|||||
|
2022
Q4 | $54.3K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $4K | Sell |
|
|||||
|
2021
Q4 | $132K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $189K | Sell |
|
|||||
|
2021
Q1 | $244K | Buy |
|
|||||
|
2020
Q4 | $64K | Buy |
|
|||||
|
2020
Q3 | $22K | Sell |
|
|||||
|
2020
Q2 | $590K | Sell |
|
|||||
|
2020
Q1 | $374K | Buy |
|
|||||
|
2019
Q4 | $676K | Buy |
|
|||||
|
2019
Q3 | $284K | Buy |
|
|||||
|
2019
Q2 | $346K | Buy |
|
|||||
|
2019
Q1 | $21K | Buy |
|
|||||
|
2018
Q4 | $18K | Buy |
|
|||||
|
2018
Q3 | $13K | Sell |
|
|||||
|
2018
Q2 | $276K | Sell |
|
|||||
|
2018
Q1 | $210K | Sell |
|
|||||
|
2017
Q4 | $224K | Sell |
|
|||||
|
2017
Q3 | $326K | Buy |
|
|||||
|
2017
Q2 | $0 | Sell |
|
|||||
|
2017
Q1 | $6K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $19K | Sell |
|
|||||
|
2016
Q2 | $21K | Buy |
|
|||||
|
2016
Q1 | $24K | Sell |
|
|||||
|
2015
Q4 | $35K | Buy |
|
|||||
|
2015
Q3 | $46K | Sell |
|
|||||
|
2015
Q2 | $172K | Buy |
|
|||||
|
2015
Q1 | $15K | Sell |
|
|||||
|
2014
Q4 | $28K | Buy |
|